In mice, brain receptors may act as brakes on chronic nerve pain

Deep in the brains of mice with nerve damage, a small group of cells appears to be pressing the accelerator on chronic pain. Researchers at Washington University School of Medicine in St. Louis found that mu opioid receptors on those cells can act as biological brakes: remove them, and the animals become more sensitive to touch and heat; restore them, and the hypersensitivity recedes.

The cells sit in the locus coeruleus, a brain region better known for regulating alertness and stress. The team first showed that nerve injury turns this region into an active driver of pain. Temporarily silencing its cells reduced pain sensitivity in mice modeling neuropathic pain, highlighting the role of this brain region in the pain response.

The receptor finding adds a mechanism. Mu opioid receptors respond to opioids produced naturally by the body, as well as medicines such as morphine and fentanyl. In the experiments, deleting the receptors only from locus coeruleus cells made the injured mice even more sensitive. Putting the receptors back into those same neurons reversed the effect, effectively switching off the pain engine.

Millions of adults live with chronic neuropathic pain caused by damaged nerves, which can produce shooting, stabbing or burning sensations. Existing opioid medicines act on receptors across the body and brain, a broad reach associated with side effects, tolerance and addiction risk, according to senior author Jordan McCall.

So what changes, concretely? The study gives researchers a more precise target: the opioid receptors in one pain-related brain region. That could eventually support treatments designed to preserve pain relief while limiting effects elsewhere. For now, the evidence comes from mice, and the researchers are still exploring how to manipulate the locus coeruleus safely; no human therapy is described.